Robert Stuart to Half-Life
This is a "connection" page, showing publications Robert Stuart has written about Half-Life.
Connection Strength
0.041
-
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. Cancer Chemother Pharmacol. 2019 07; 84(1):163-173.
Score: 0.041